Loading clinical trials...
Loading clinical trials...
Pilot Therapeutic Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia
Conditions
Interventions
Sofosbuvir/Daclatasvir
Locations
4
Cambodia
Battambang Provincial Hospital
Battambang, Cambodia
Kantha Bopha Hospital
Phnom Penh, Cambodia
National Pediatric Hospital
Phnom Penh, Cambodia
Jayavarman VII Hospital
Siem Reap, Cambodia
Start Date
August 7, 2023
Primary Completion Date
January 31, 2026
Completion Date
January 31, 2026
Last Updated
December 4, 2025
NCT06928259
NCT05534633
NCT07412977
NCT07241962
NCT04134767
NCT04353986
Lead Sponsor
ANRS, Emerging Infectious Diseases
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions